FOR IMMEDIATE RELEASE
Houston, TX – April 8th, 2025 – IPSE, a leading securitization firm specializing in motion pictures, industrial, technological, medical, pharmaceutical patents, and music, has announced a major financial reporting update.
In preparation for its Initial Public Offering (IPO), IPSE has completed the conversion of its balance sheets for the last five years from International Financial Reporting Standards (IFRS) to U.S. Generally Accepted Accounting Principles (USGAAP).
This shift notably integrates signed contract values as discounted effective goodwill, dramatically enhancing IPSE’s financial transparency and corporate valuation.
Previously, IPSE adhered to an ultra-conservative accounting strategy, valuing its assets strictly at historical cost.
The company did not account for future revenue streams despite holding signed contracts for over a year. Until recently, IPSE’s financial projections included only motion picture contracts signed with Exodus.
The adoption of USGAAP allows IPSE to now fully reflect projected revenues across all its sectors, including motion pictures, industrial and technological innovations, medical and pharmaceutical patents, and music securitization.
“This transition to USGAAP significantly clarifies IPSE’s financial health and potential,” stated Dourgam Kummer, IPSE’s CAO. “By integrating future revenue from all our securitized sectors into our balance sheets as effective discounted goodwill, we can now provide investors a more accurate picture of our true market value and growth potential.”
IPSE has proactively reached out to the mid-market accounting firms as well as to the Big Four audit firms.
It is currently in the process of selecting a premier audit firm to ensure the highest standards in financial auditing and transparency.
This comprehensive revision of IPSE’s accounting practices underscores Swiss Financiers SA’s recent evaluation, which stated, “At USD 250 million valuation, IPSE is grossly undervalued.”
With the updated financial statements and the incorporation of projected revenues across all business segments, IPSE’s intrinsic value is now transparent and substantially higher.
IPSE anticipates this enhanced financial reporting will strengthen investor confidence, attract strategic partnerships, and more accurately reflect the company’s significant market opportunities.
About IPSE
IPSE is a premier securitization firm specializing in diverse intellectual property assets, including motion pictures, industrial technologies, medical and pharmaceutical patents, and music. IPSE transforms intellectual property into accessible financial instruments, unlocking substantial value and investment opportunities.
Contact Information:
Skender Djendoubi
skender@IPSEcorp.com
www.IPSEcorp.com
